Immunicom
San Diego
About Immunicom
Immunicom is redefining the limits of immunotherapy through the development of innovative, non-pharmaceutical treatment approaches for cancer, inflammatory diseases, and autoimmune diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $23.9M
- Funding stage: Early Stage Venture
- Last round: Grant (Jun 2022)
- Website: immunicom.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/immunicom-130469 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.